Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class

Investing Profile

Nina Kjellson

VCInvestor

General Partner at Canaan Partners

canaan.com/team/nina-kjellsonMenlo Park, California
Photo of Nina Kjellson, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
22
$800M
CompanyStageDateRound SizeTotal Raised
Vineti
Series COct 2020$33M
Series BApr 2018$34M
$67M
Co-investors: Mike Pellini (Section 32)
Dauntless Pharmaceuticals
Series AFeb 2017$25M
$37M
Co-investors: David Kabakoff (HealthQuest Capital)
Tizona Therapeutics
Series BMar 2016$43M
$43M
Welltok
Series DJan 2015$37M
Series CFeb 2014$22M
Series BApr 2013$19M
$160M
Co-investors: Kevin Spain (Emergence Capital), Lily Huang (New Enterprise Associates (NEA)), Mohamad Makhzoumi (New Enterprise Associates (NEA)), Blake Wu (New Enterprise Associates (NEA)), Michael Greeley (Flare Capital Partners), Sharon Stevenson (Okapi Venture Capital)
Cidara Therapeutics
Series AJun 2014$32M
$32M
Ocera Therapeutics
Post-IPO EquityNov 2013$28M
$28M
Labrys Biologics
Series AJan 2013$31M
Venture RoundDec 2012$15M
$46M
Co-investors: Wende Hutton (Canaan Partners)
Cebix
Series BOct 2012$33M
Venture RoundSep 2010$16M
$49M
Co-investors: Lars Ekman (Sofinnova Investments)